Dermapharm Holdings' IPO

Dermapharm Holdings raised a round of funding on February 09, 2018. Investors include Public.

Dermapharm Holdings is a manufacturer of patent-free branded pharmaceuticals for selected markets. The company's integrated business model includes in-house development, in-house production, and distr…

Articles about Dermapharm Holdings' IPO: